JPRN-UMIN000025638已完成未知
Adenosine A2A receptors in Parkinson's disease - Adenosine A2A receptors in Parkinson's disease
Tokyo Metropolitan Institute of Gerontology0 个研究点目标入组 40 人开始时间: 2017年1月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40years-old 至 89years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. The subjects with a history of brain diseases, excluding than cerebellar diseases. 2. The subjects who are prescribed a medication for the central nervous system. 3. The subject who have chronic dysfunction in the organs. 4. Pregnant or woman who has a chance of pregnant. 5. The subjects who were judged by the clinical investigator to be inappropriate as a participant in this study.
研究者
相似试验
已完成
2 期
KW-6002 to Treat Parkinson's DiseaseParkinson's DiseaseNCT00006337National Institute of Neurological Disorders and Stroke (NINDS)16
招募中
不适用
PADNI: Parkinson's and Alzheimer's disease Dimensional Neuroimaging InitiativeAlzheimer's disease (AD), Parkinson's disease (PD) and AD/PD related disordersJPRN-UMIN000036297atinal Center of Neurology and Psychiatry615
已完成
2 期
Dose-Response of Adenosine for Perioperative PainPerioperative PainNCT00298636Xsira Pharmaceuticals160
已完成
2 期
JP-1730 to Treat Parkinson's DiseaseParkinson DiseaseNCT00040209National Institute of Neurological Disorders and Stroke (NINDS)30
进行中（未招募）
1 期
Dopaminergic therapy for Alzheimer's disease patientsMedDRA version: 20.0Level: PTClassification code 10012271Term: Dementia Alzheimer's typeSystem Organ Class: 10029205 - Nervous system disordersAlzheimer's diseaseEUCTR2015-002965-43-ITI.R.C.C.S. FONDAZIONE S.LUCIA130